INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-74 Cr | ₹98 Cr | ₹142 Cr | ₹155 Cr | ₹93 Cr |
What is the latest Consolidated Net Profit of INDOCO REMEDIES ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹-74 Cr |
Mar2024 | ₹98 Cr |
Mar2023 | ₹142 Cr |
Mar2022 | ₹155 Cr |
Mar2021 | ₹93 Cr |
How is Consolidated Net Profit of INDOCO REMEDIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹-74 Cr | Negative | |
Mar2024 | ₹98 Cr | -30.78 | |
Mar2023 | ₹142 Cr | -8.11 | |
Mar2022 | ₹155 Cr | 66.37 | |
Mar2021 | ₹93 Cr | - |
Compare Consolidated Net Profit of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹2,804.3 Cr | 9.9% | 6.7% | -21.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,497.0 Cr | 1.1% | -1.9% | -14.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,787.0 Cr | 1.1% | -0.6% | 10.4% | Stock Analytics | |
CIPLA | ₹125,870.0 Cr | -0.4% | -0.4% | -6.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,591.0 Cr | -1.7% | -2.5% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,380.0 Cr | 0.5% | 4.1% | -2.7% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | 9.9% |
6.7% |
-21.3% |
SENSEX | 1.6% |
2.3% |
1.1% |
You may also like the below Video Courses